Potential Role of Nuclear Factorκ B in Diabetic Cardiomyopathy
Author(s) -
Óscar Lorenzo,
Belén Picatoste,
S. Ares-Carrasco,
Elisa Ramírez,
Jesús Egido,
José Tuñón
Publication year - 2011
Publication title -
mediators of inflammation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.37
H-Index - 97
eISSN - 1466-1861
pISSN - 0962-9351
DOI - 10.1155/2011/652097
Subject(s) - diabetic cardiomyopathy , transcription factor , diabetes mellitus , cardiomyopathy , oxidative stress , medicine , vascular endothelial growth factor , inflammation , endocrinology , bioinformatics , heart failure , biology , gene , vegf receptors , genetics
Diabetic cardiomyopathy entails the cardiac injury induced by diabetes independently of any vascular disease or hypertension. Some transcription factors have been proposed to control the gene program involved in the setting and development of related processes. Nuclear factor-kappa B is a pleiotropic transcription factor associated to the regulation of many heart diseases. However, the nuclear factor-kappa B role in diabetic cardiomyopathy is under investigation. In this paper, we review the nuclear factor-kappa B pathway and its role in several processes that have been linked to diabetic cardiomyopathy, such as oxidative stress, inflammation, endothelial dysfunction, fibrosis, hypertrophy and apoptosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom